denileukin diftitox/dexamethasone

Known as: DAB389-IL2/DM 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2009
01220022009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
INTRODUCTION Denileukin diftitox, a chimeric protein, uses the cytocidal properties of diphtheria toxin to cells expressing… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
CD4+CD25+Foxp3+ regulatory T (Treg) cells have been implicated in the lack of effective antitumor immunity. Denileukin diftitox… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2006
2006
BACKGROUND Denileukin diftitox, a fusion protein consisting of peptide sequences for the enzymatically active and membrane… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Elimination of regulatory T lymphocytes may provide a way to break self-tolerance and unleash the anti-tumor properties of… (More)
Is this relevant?
2002
2002
Cutaneous T-cell lymphoma (CTCL) can be associated with painful, pruritic, disfiguring lesions. As part of a multicenter… (More)
Is this relevant?